Boting Ning

Boting Ning possesses extensive research experience in the biomedical field, having contributed to various prestigious institutions. As a Research Assistant at Boston University School of Medicine, Boting participated in the Framingham Heart Study, developing predictive models for neuropsychological and MRI outcomes. A PhD candidate in Dr. Avrum Spira and Dr. Marc Lenburg's lab at Boston University School of Medicine, Boting identified key miRNA involved in lung cancer progression and created the R package `DReAmiR`. Previous roles included positions at Vanderbilt University, where Boting investigated DNA replication mechanisms, and at Epidemico, where Boting facilitated machine learning classifier development. Currently, Boting serves as a Principal Scientist in Biomarker Analytics at Johnson & Johnson, following a progression from Senior Scientist. Boting holds a Master of Public Health in Biostatistics and a PhD in Bioinformatics from Boston University, as well as a Bachelor of Arts in Molecular and Cellular Biology from Vanderbilt University.